Dhanvantri Jeevan Rekha Limited has filed its quarterly compliance certificate with BSE Limited, fulfilling regulatory requirements under SEBI (Depositories and Participants) Regulations, 2018. The healthcare services company submitted the mandatory certificate for the quarter ended 31st March 2026.

Regulatory Compliance Filing

The certificate was submitted pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. Company Secretary Ritika Bhandari (ACS: A60961) filed the document with BSE Limited on 17th April 2026, addressing it to the exchange's management at P.J. Towers, Dalal Street, Fort, Mumbai.

Registrar Confirmation

M/s Beetal Financial & Computer Services (P) Ltd., serving as the company's registrar and share transfer agent, issued the compliance certificate dated 03rd April 2026. The SEBI-approved Category I registrar (SEBI Reg. No.: INR 000000262) confirmed adherence to dematerialization requirements during the quarter ended March 2026.

Beetal Financial confirmed that securities received from depository participants for dematerialization during the quarter were properly processed and confirmed to the depositories. The registrar also verified that security certificates received for dematerialization were mutilated and cancelled after due verification, with depositories' names substituted in the register of members within the prescribed 15-day timeline.

Company Background

Dhanvantri Jeevan Rekha Limited operates Dhanvantri Hospital, a healthcare facility located in Saket, Meerut, Uttar Pradesh. The company holds ISO 9001:2015 certification and maintains NABH pre-accreditation status. The hospital is incorporated under CIN No. L85110UP1993PLC015458 and operates with GSTIN No. 09AAACD5774B1ZS.

Regulatory Framework

The filing references multiple regulatory circulars including NSDL/CIR/II/5/2019 dated 25th January 2019, CDSL/OPS/RTA/POLCY/2019/14 dated 25th January 2019, and SEBI letter ref no. MRD/DOP2/DSA2/OW/2019/2498/1 dated 24th January 2019. These regulations ensure proper handling of securities dematerialization processes and maintain transparency in depository operations.

The quarterly certificate submission demonstrates the company's commitment to regulatory compliance and transparent corporate governance practices in the healthcare sector.

Dhanvantri Jeevan Rekha Limited has published its unaudited financial results for the third quarter of fiscal year 2026 in newspapers, complying with SEBI regulations. The Meerut-based company reported strong revenue growth and maintained profitability during the quarter ended 31st December 2025.

Financial Performance Overview

The company's quarterly performance demonstrates positive momentum in revenue generation. Net sales from operations increased significantly during the quarter, while the company maintained profitability despite challenging market conditions.

Operational Expenses Analysis

The company's expense structure showed mixed trends during the quarter. Cost of material consumed increased to Rs 184 lacs from Rs 138 lacs in the previous year quarter. Employee benefit expenses rose to Rs 107 lacs compared to Rs 99 lacs in Q3FY25. Other expenditure increased to Rs 409 lacs from Rs 318 lacs in the corresponding quarter last year.

Nine-Month Performance

For the nine-month period ended 31st December 2025, the company reported net sales of Rs 1,862 lacs compared to Rs 1,682 lacs in the corresponding period of the previous year. However, profit for the nine-month period declined to Rs 9 lacs from Rs 47 lacs in the previous year period.

Earnings Per Share and Capital Structure

The company maintained its paid-up equity share capital at Rs 410 lacs with a face value of Rs 10 per share. Basic and diluted earnings per share for the quarter stood at Rs 0.41 compared to Rs 0.36 in Q3FY25. For the nine-month period, EPS was Rs 0.22 against Rs 1.15 in the previous year.

Regulatory Compliance and Publication

Pursuant to Regulation 47 of SEBI (LODR) Regulations, 2015, the company published its financial results in Jansatta (Hindi Edition) and Financial Express (English Edition) on 13th February 2025. Company Secretary and Compliance Officer Ritika Bhandari submitted the newspaper clippings to BSE Limited for compliance purposes.

The financial results were reviewed by the company's statutory auditors Anuj Goyal & Co., Chartered Accountants, and approved by the Audit Committee. The Board of Directors took the results on record in their meeting held on 12th February 2026, which commenced at 12:00 PM and concluded at 04:30 PM. The results have been prepared in compliance with Indian Accounting Standards (Ind-AS) and filed under Regulation 33 of SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.